Copyright
©The Author(s) 2015.
World J Gastroenterol. May 28, 2015; 21(20): 6271-6279
Published online May 28, 2015. doi: 10.3748/wjg.v21.i20.6271
Published online May 28, 2015. doi: 10.3748/wjg.v21.i20.6271
Table 1 Correlation between NADPH oxidase 2 expression and clinical-pathological characters in gastric cancer n (%)
| Clinical feature | Total number (n = 123) | NOX2 positivity negativity | χ2-value | P-value |
| Gender | ||||
| Male | 69 | 30 (43.5) | 0.852 | 0.229 |
| 39 (56.5) | ||||
| Female | 54 | 28 (51.9) | ||
| 26 (48.1) | ||||
| Age (yr) | ||||
| < 59 | 55 | 27 (49.1) | 0.150 | 0.419 |
| 28 (50.9) | ||||
| ≥ 59 | 68 | 31 (45.6) | ||
| 37 (54.4) | ||||
| Position | ||||
| Cardia and fundus | 30 | 8 (26.6) | 6.683 | 0.008 |
| 22 (73.3) | ||||
| Body and antrum | 93 | 50 (53.8) | ||
| 43 (46.2) | ||||
| Differentiation type | ||||
| High | 22 | 6 (27.3) | 5.062 | 0.042 |
| 16 (72.7) | ||||
| Moderate | 34 | 16 (47.1) | ||
| 18 (52.9) | ||||
| Poor | 62 | 34 (54.8) | ||
| 28 (45.2) | ||||
| Undifferentiation | 5 | 2 (40) | ||
| 3 (60) | ||||
| Lymph node metastasis | ||||
| Yes | 53 | 34 (64.2) | 10.796 | 0.001 |
| 19 (35.8) | ||||
| No | 70 | 24 (34.3) | ||
| 46 (65.7) | ||||
| Vascular invasion | ||||
| Yes | 60 | 35 (58.3) | 5.875 | 0.012 |
| 25 (41.7) | ||||
| No | 63 | 23 (36.5) | ||
| 40 (63.5) | ||||
| Clinical stage | ||||
| Early stage | 32 | 9(28.1) | 6.285 | 0.010 |
| 23(71.9) | ||||
| Advanced stage | 91 | 49(53.8) | ||
| 42(46.2) | ||||
| TNM | ||||
| I + II | 35 | 10(28.6) | 6.779 | 0.008 |
| 25(71.4) | ||||
| III + IV | 88 | 48(68.6) | ||
| 40(31.4) | ||||
Table 2 Univariate analysis of clinicopathological features for the prognosis in 123 gastric cancer patients
| Variable | Coef | SE | Wald | RR value (95%CI) | P-value |
| Clinical stage | 0.531 | 0.221 | 5.7970 | 1.701 (1.104-2.620) | 0.016 |
| Differentiation type | 0.363 | 0.193 | 3.5250 | 1.438 (0.984-2.101) | 0.060 |
| Lymph node metastasis | 0.971 | 0.213 | 20.857 | 0.379 (0.250-0.575) | 0.000 |
| Vascular invasion | 0.926 | 0.198 | 21.854 | 0.396 (0.269-0.584) | 0.000 |
| TNM | 0.638 | 0.214 | 8.9030 | 1.892 (1.245-2.876) | 0.003 |
| NOX2 | 1.080 | 0.212 | 26.004 | 0.339 (0.224-0.514) | 0.000 |
Table 3 Multivariate analysis of clinicopathological features for the prognosis in 123 gastric cancer patients
| Variable | Coef | SE | Wald | RR value (95%CI) | P-value |
| Clinical stage | 0.670 | 0.236 | 8.0800 | 1.955 (1.230-3.103) | 0.004 |
| Differentiation type | 0.176 | 0.201 | 0.7710 | 1.193 (0.805-1.769) | 0.380 |
| Lymph node metastasis | 0.760 | 0.232 | 10.725 | 0.468 (0.297-0.737) | 0.001 |
| Vascular invasion | 1.061 | 0.220 | 23.330 | 0.346 (0.225-0.532) | 0.000 |
| TNM | 0.519 | 0.229 | 5.1360 | 0.637 (0.406-0.999) | 0.049 |
| NOX2 | 0.824 | 0.236 | 12.153 | 0.439 (0.276-0.697) | 0.000 |
- Citation: Wang P, Shi Q, Deng WH, Yu J, Zuo T, Mei FC, Wang WX. Relationship between expression of NADPH oxidase 2 and invasion and prognosis of human gastric cancer. World J Gastroenterol 2015; 21(20): 6271-6279
- URL: https://www.wjgnet.com/1007-9327/full/v21/i20/6271.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i20.6271
